Back to results
TerminatedPhase 4

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

NCT00936663

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Nebraska Medical Center

Omaha, Nebraska, United States

View on ClinicalTrials.gov
Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation — TrialFind